Tag : bi journal articles

Top Voices

Business Insight Journal Interview with Dean Margolis, Co-Founder and CEO, Red Sky Health

BI Journal
Why outcome-linked technology models are reshaping accountability, ROI, and revenue recovery in healthcare operations. Dean, as the Co-Founder and CEO of Red Sky Health, you’ve...
Communication, Media and Technology (Telecommunications)The Inner Circle

Accelerating Enterprise Innovation with Private 6G Testbeds: The Strategic Crossroads of 2026

BI Journal
Accelerating enterprise innovation with private 6G testbeds at the 2026 strategic crossroads of AI-native, sensing-driven networks. The race to the 6G leadership is no longer...
BFSIThe Inner Circle

How Predictive Analytics is Shaping the Future of Post‑Trade Decisions

BI Journal
With predictive analytics, post-trade operations within financial institutions are changing from reactive and labor-intensive processes into proactive and data-driven operations. Through machine learning, statistical modeling...
Manufacturing & EngineeringThe Inner Circle

Bio-Based Materials for Smart and Sustainable Electronics Technologies

BI Journal
Using renewable materials in electronics manufacturing creates circular devices that perform like conventional tech but return safely to nature Bio-based materials are quietly reshaping smart...
Real estate & constructionThe Inner Circle

Industrialized Construction: Lean Production, Modular Mass-Assembly & Off-Site Fabrication

BI Journal
Explore industrialized construction: lean production, modular mass-assembly, and off-site fabrication for faster, cost-efficient, and sustainable building projects. The industrialized construction is transforming the delivery process...
Leadership, Strategy & Decision Making

NACD Honors Melissa Ludwig with Directorship 100 & Board Award

Business Wire
Chapter Expands Its Reach and Influence Amid a Rapidly Evolving Corporate Governance Landscape The Philadelphia Chapter of the National Association of Corporate Directors (NACD) announced...
Clinical Research, Pharma & Healthcare Financing

Tenpoint Raises $235M to Launch YUVEZZI™ for Presbyopia

Business Wire
U.S. FDA Approves YUVEZZI™ as the only dual-agent, once daily presbyopia-correcting eye drop Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking...